# SAKAR (SAKAR)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹786.75
Day Change: -2.75%
52W High: ₹709.7
52W Low: ₹305.05
Market Cap: ₹1,529 Cr

## Valuation
P/E: 61.11
P/B: 5.11
EPS: ₹11.4
Book Value: ₹136.29
Dividend Yield: 0%

## Returns
1Y Return: 93.02%

## Profitability
ROE: 10%
ROCE: 14.22%
Debt/Equity: 0.17
Revenue Growth: 40.4%
Profit Growth: 87.2%
EBITDA Margin: 28.02%
Operating Margin: 28.72%

## About
SAKAR is a Pharma company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Unknown
Sub Industry: Unknown

## Business Model
Overview: SAKAR makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Pharma. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.

## Access
Current tier: anonymous
More history: Register free to see 3 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:04.699Z
Price History Updated: 2026-05-15T18:53:06.857Z
Latest Price History Date: 2026-05-14
Technicals Updated: 2026-05-15T18:53:06.857Z
Quant Updated: 2026-05-15T18:53:06.857Z
Sentiment Updated: 2026-05-15T18:53:06.857Z
Financials Status: current
Financials Updated: 2026-05-18T10:30:01.379Z
Financials Last Attempt: 2026-05-18T10:30:01.379Z
Financials Provider Tried: database
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2021)
Revenue: ₹83 Cr
Operating Profit: ₹20 Cr (OPM 24%)
Net Profit: ₹10 Cr
Tax: ₹12 Cr

## Annual P&L History
Mar 2021: Rev ₹83Cr | PAT ₹10Cr | OPM 24%
Mar 2022: Rev ₹95Cr | PAT ₹11Cr | OPM 24%
Mar 2023: Rev ₹128Cr | PAT ₹15Cr | OPM 23%

## Balance Sheet (Mar 2021)
Total Assets: ₹115 Cr
Total Liabilities: ₹115 Cr
Borrowings: ₹17 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Sanjay Surendra Shah, Chairman & MD
- Aarsh Sanjay Shah, MD & Executive Director
- Sunil Vasantrao Marathe, Technical Director & Whole Time Director
- Dharmesh R. Thaker, Chief Financial Officer
- Sudhir  Ghuleas, Chief Operating Officer

---
Source: rupiya.io/stocks/sakar
Disclaimer: For research and education only. Not investment advice.